venting postoperative atrial fibrillation. In an effort to confirm the efficacy of prophylaxis with quinidine, the following prospective study was undertaken.
Groups Studied and Method One hundred consecutive patients in sinus rhythm admitted to Walter Reed General Hospital for closed mitral valvotomy during the period April 1961 to January 1965 were included in this study. Patients were assigned alternately to the control and study groups. In the study group quinidine prophylaxis (200 mg every 6 hours for those weighing less than 120 pounds; 300 mg every 6 hours for those weighing more than 120 pounds) was begun immediately after surgery and continued for 10 days. Initial therapy consisted of quinidine gluconate given intramuscularly; a change to oral therapy was made as soon as it could be tolerated. In all other respects the two groups received identical treatment.
The treated group contained 14 males, while the untreated group contained three males. The two groups were otherwise comparable in respect to race, age, weight, associated mitral insufficiency, history of palpitation, size of the mitral orifice at surgery, calcification of the valve, electrocardiographic evidence of left atrial enlargement, anesthesia employed, as well as functional and therapeutic classification. There were six cases of repeat commissurotomy in the group receiving quinidine, and 10 in the control group. Practically all patients were digitalized at the time of surgery. In all but five patients a mechanical transventricular dilator was utilized to ensure wide splitting of the mitral commissures. Results
The incidence of postoperative atrial fibrillation was equal in the treated and the control group (table 1). The 16% overall incidence of atrial fibrillation was considerably lower than in most reported series. In 10 patients the fibrillation was transitory and the heart reverted to sinus rhythm spontaneously or following small doses of anti-arrhythmic drugs before the patients left the hospital. Of the six patients who developed permanent atrial fibrillation, four had not received quinidine, and two had received prophylactic quinidine therapy. The difference between the two groups was not statistically significant. Our groups showed a statistically significant, higher incidence of atrial fibrillation in patients beyond 40 years of age. Quinidine, however, proved singularly ineffective in preventing the arrhythmia in this particularly vulnerable group (table 2) .
Discussion
The results of this prospective study are in agreement with the experience of Heinz and dine did not reduce the likelihood of developand associates5 and ing the arrhythmia in the patients beyond 40 in moderate dosage is years of age. In this age group the incidence g the incidence of post-of postoperative atrial fibrillation was nearly Llation following mitral 50% among both the treated and untreated to confirm the efficacy patients. Numerous authors have pointed out axis reported by Black that older patients are more prone to develop Little and Crockett. 3 The atrial fibrillation following mitral valvotoemployed in this study my. 2' 6, 8 This was confirmed in our study. iat advocated by Black
Others have indicated that preoperative digiwas significantly lower talization probably tends to prevent this ar-Lngerous levels employed rhythmia.9 Virtually all of our patients were :t. There was one opera-digitalized prior to surgery, and this probably 100 patients; this death contributed to the low incidence of fibrillation. idine-treated group and Another possible factor is improved anesplex arrhythmia in the thesia and surgical techniques with the paseriod 1 hour after the sage of years, so that recent studies will comhis initial intramuscular pare favorably with earlier ones. Some workers conate. Although quini-have noted that atrial fibrillation rarely occurs plicated as the cause of during surgery but usually appears during it be clearly exonerated.
the first week of convalescence.2 4 6 10 This the overall incidence of was our experience. None of the patients in I) was considerably less our treated group developed atrial fibrillation reports, even though 16 before receiving quinidine. Hence, there Circulation, Volume XXXIV, Novembe-1966 McCARTY ET AL.
seems to be no virtue in initiating prophylactic quinidine therapy in the preoperative period, and it appears undesirable to administer a myocardial depressant prior to anesthesia and cardiac surgery. An increased incidence of postoperative atrial fibrillation has been reported also in male patients and in patients with a history of palpitation.7 However, a statistically significant increase was not noted in such patients in this study. Similarly, the severity of stenosis as judged by the size of the orifice at surgery, the incidence and magnitude of postoperative mitral insufficiency, the type of anesthesia, the degree of left atrial enlargement as evidenced by changes in ECG, calcification of the mitral valve, or previous valve surgery did not affect the incidence of the arrhythmia in this study.
In this controlled, prospective study the prophylactic use of quinidine was ineffective in preventing postoperative atrial fibrillation in patients undergoing closed mitral commissurotomy, and its routine use for this purpose does not seem warranted.
Summary
One hundred patients in sinus rhythm who underwent closed mitral commissurotomy were divided alternately into two comparable groups. One group received prophylactic treatment with quinidine immediately after operation for a period of 10 days. The incidence of atrial fibrillation was 16% in both the treated and the untreated groups. In patients more than 40 years of age, the incidence of postoperative atrial fibrillation was much higher (48%). However, in these older, more vulnerable patients quinidine prophylaxis was no more effective than it was in the younger age groups. The only operative death in the entire series occurred in the treated group and could have been due to quinidine. In this controlled, prospective study the use of quinidine in moderate dosage was ineffective in preventing postoperative atrial fibrillation following mitral commissurotomy. Its routine use is not recommended.
